Results 61 to 70 of about 205 (151)

Cardioprotective measures in patients with cardiovascular risk factors and polymorbidity

Лечащий Врач, 2022
4th international educational forum «Russian Days of the Heart» took place in St. Petersburg, 22 June 2022. Its program included a satellite symposium «Actual cardioneurology: cardiovascular risk factors and polymorbidity» that was held with the support ...
article Editorial
doaj  

COMPARATIVE EFFECTIVENESS OF CARDIOCYTE PROTECTORS IN COMPLEX MANAGEMENT OF ARTERIAL HYPERTENSION

Российский кардиологический журнал, 2009
The study investigated the effects of cardiocyte protectors, mexicor and mildronate, in combination with ACE inhibitors, on blood levels of lipid peroxidation products, vascular endothelial function, circadian profile of blood pressure, and left ...
F. E. Khlebodarov, V. P. Mikhin, A. V. Gorlova   +2 more
doaj  

The 6th Iberian and 2nd Ibero-American Cyanotoxin Congress CIC2019. [PDF]

Toxins (Basel), 2021
Aboal M.
europepmc   +1 more source

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use

Cardiovascular Therapy and Prevention, 2019
The clinical case of the successful use of the myocardial cytoprotector trimetazidine as a universal anti-ischemic agent in a patient with hemodynamic angina due to myocardial bridging is described. The pathogenetic rationale for this prescription is presented.
O. V. Tsygankova, L. D. Latyntseva, T. I. Batluk, D. Yu. Platonov, N. M. Akhmedzhanov   +4 more
openaire   +3 more sources

gp130 Activates Mitochondrial Dynamics for Hepatocyte Survival in a Model of Steatohepatitis. [PDF]

Biomedicines, 2023
Shunkina D, Dakhnevich A, Shunkin E, Khaziakhmatova O, Shupletsova V, Vulf M, Komar A, Kirienkova E, Litvinova L.   +8 more
europepmc   +1 more source

Food allergy

Терапевтический архив, 2011
Food allergy (FA) - a condition of high sensitivity to food products - is widely spread allergic disease treated by allergologists, gastroenterologists, dermatologists, physicians, pulmonologists.
Elena Vladimipovna Luzina, Irina Kimovna Bogomolova, Viktor Nikolaevich Tereshchenko, E V Luzina, I K Bogomolova, V N Tereschenko   +5 more
doaj  

Secondary prevention effectiveness in patients with stable angina

Кардиоваскулярная терапия и профилактика, 2010
Aim. To assess the effectiveness of pharmaceutical secondary prevention in ambulatory patients with stable angina (SA), in the real-worl clinical settings. Material and methods.
Rasim Kutlu, T. M. Murataliev
doaj  

ENDOTHELIAL DYSFUNCTION AND ITS CORRECTION WIT CYTOPROTECTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND ARTERIAL HYPERTENSION

Российский кардиологический журнал, 2009
The study compared the effects of cardiocytoprotectors (mildronate, trimetazidine) on endothelial function, physical stress tolerability, and circadian blood pressure (BP) profile in patients with arterial hypertension (AH; n=60) and stable angina (n=82),
F. E. Khlebodarov, P. Yu. Turikov, V. P. Mikhin   +2 more
doaj  

Leukocyte as an adequate model for studying changes in energy metabolism in heart cells under the influence of cardiocytoprotectors in myocardial ischemia

Acta Biomedica Scientifica
The aim of this study was to determine the possibility of studying the nature of the influence of cardiocytoprotectors on energy metabolism in cardiomyocytes using a model of human peripheral blood leukocytes.Materials and methods. Sixty Wistar rats were
A. L. Khokhlov, O. V. Romashchenko, V. V. Rumbesht, T. I. Yakunchenko, N. I. Zhernakova, L. R. Zakirova, V. G. Kukes   +6 more
doaj   +1 more source

Therapeutic possibilities of myocardial cytoprotector trimetazidine MR incoronary heart disease

CardioSomatics, 2014
The results of numerous foreign and Russian researches allow us to consider trimetazidine MR as an essential component of effective therapy in patients with coronary heart disease. The article highlights the proven and promising therapeutic possibilities trimetazidine MR.
openaire   +2 more sources